Inovio Brass Hit With Suit Over FDA Approval Claims
Executives and directors of Inovio Pharmaceuticals Inc. on Wednesday were slapped with a shareholder derivative suit accusing them of damaging the company with misleading statements regarding the likelihood that the U.S....To view the full article, register now.
Already a subscriber? Click here to view full article